You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. CASSAVA SCIENCES INC

Cassava Sciences Inc XNAS: SAVA

Cassava Sciences Inc Live Share Price Today, Share Analysis and Chart

Download real time

2.72 -0.07 (-2.51%)

93.55% Fall from 52W High

896.2K XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
12.0 / 100
Momentum Score
Technically Bearish
25.6 / 100
Analyst Price Target
No estimates available

6

S

10

W

1

O

2

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Cassava Sciences Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Cassava Sciences Inc Stock Analysis

Cassava Sciences Inc stock analysis with key metrics, changes, and trends.

Cassava Sciences Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Net Profit$24.34 M74.96%positive

Annual Net Profit rose 74.96% in the last year to $24.34 M. Its sector's average net profit growth for the last fiscal year was -32.39%.

Price to Earning Ratio-5.4-negative

Price to Earning Ratio is -5.4, which is negative.

Stock Price$2.72-87.63%negative

Stock Price fell 87.63% and underperformed its sector by 97.18% in the past year.

Quarterly Net profit$27.6 M31.92%negative

Quarterly Net profit fell 31.92% YoY to $27.6 M. Its sector's average net profit growth YoY for the quarter was -47.48%.

Mutual Fund Holding20.68 %-2.16%negative

Mutual Fund Holding decreased by 2.16% in the last quarter to 20.68.

Promoter Share Holding5.70 %0%neutral

Promoter Share Holding stayed the same in the most recent quarter at 5.7%.

Institutional Holding35.29 %5.76%positive

Institutional Holding increased by 5.76% in the last quarter to 35.29.

VIEW LESS


Loading data..

Cassava Sciences Inc - Company Profile

What does Cassava Sciences Inc do?

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Cassava Sciences Inc Management structure

All Gross Remunerations are in USD
Mr. Remi Barbier
Chairman of the Board, President and Chief Executive Officer
-
2024
Gross Remuneration
Year
Mr. Richard J. Barry
President, Chief Executive Officer and Director
-
2024
Gross Remuneration
Year
Mr. Eric Schoen
Chief Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year
Dr. James W. Kupiec, M.D.
Chief Medical Officer and Chief Clinical Development Officer
-
2024
Gross Remuneration
Year
Mr. R. Christopher Cook
Senior Vice President and General Counsel
-
2024
Gross Remuneration
Year

Cassava Sciences Inc Board of directors

All Gross Remunerations are in USD
Mr. Remi Barbier
Chairman of the Board, President and Chief Executi
-
2024
Gross Remuneration
Year
Dr. Claude Nicaise,M.D.
Chairman of the board
-
2024
Gross Remuneration
Year
Dr. Patrick J. Scannon,M.D.,PhD
Independent Director
-
2024
Gross Remuneration
Year
Mr. Michael J. O'Donnell, Esq.
Independent Director
-
2024
Gross Remuneration
Year
Dr. Robert Z. Gussin, PhD
Independent Director
-
2024
Gross Remuneration
Year
Mr. Richard J. Barry
President, Chief Executive Officer and Director
-
2024
Gross Remuneration
Year

Cassava Sciences Inc FAQ

How is Cassava Sciences Inc today?
Cassava Sciences Inc today is trading in the red, and is down by -2.51% at 2.72.
Cassava Sciences Inc is currently trading down -2.51% on an intraday basis. In the past week the stock fell -0.37%. stock has been up 12.40% in the past quarter and fell -87.63% in the past year. You can view this in the overview section.